Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
JY Chang, RJ Mehran, L Feng, V Verma, Z Liao… - The Lancet …, 2021 - thelancet.com
Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an …
JY Chang, SH Lin, W Dong, Z Liao, SJ Gandhi, CM Gay… - The Lancet, 2023 - thelancet.com
Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or …
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or …
[HTML][HTML] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of …
Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …
Advances in proton therapy in lung cancer
MAL Vyfhuis, N Onyeuku, T Diwanji… - Therapeutic …, 2018 - journals.sagepub.com
Lung cancer remains the leading cause of cancer deaths in the United States (US) and
worldwide. Radiation therapy is a mainstay in the treatment of locally advanced non-small …
worldwide. Radiation therapy is a mainstay in the treatment of locally advanced non-small …
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Stereotactic ablative radiotherapy (SABR) is a standard-of-care for medically-inoperable-
early-stage non-small cell lung cancer (NSCLC). One third of patients progress and …
early-stage non-small cell lung cancer (NSCLC). One third of patients progress and …
Stereotactic body radiotherapy for early-stage non–small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation …
BJ Schneider, ME Daly, EB Kennedy… - Journal of Clinical …, 2018 - ascopubs.org
Purpose The American Society for Radiation Oncology (ASTRO) produced an evidence-
based guideline on treatment with stereotactic body radiotherapy (SBRT) for patients with …
based guideline on treatment with stereotactic body radiotherapy (SBRT) for patients with …
Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (≥ 5 centimeter) non-small cell lung cancer
Purpose Stereotactic body radiation therapy (SBRT) for≥ 5 cm lesions is poorly defined,
largely owing to the low sample sizes in existing studies. The present analysis examined the …
largely owing to the low sample sizes in existing studies. The present analysis examined the …
[HTML][HTML] Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances
NT Sebastian, M Xu-Welliver… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
The standard-of-care treatment for early-stage non-small cell lung cancer (NSCLC)
continues to be surgery in the form of lobectomy or pneumonectomy. Stereotactic body …
continues to be surgery in the form of lobectomy or pneumonectomy. Stereotactic body …
Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer
MJ Baine, V Verma, CA Schonewolf, C Lin… - Lung cancer, 2018 - Elsevier
Background Contrary to prevailing notions of uniform efficacy regarding stereotactic body
radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report …
radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC), a recent report …
Combining immunotherapy with radiation therapy in non–small cell lung cancer
K Fitzgerald, CB Simone - Thoracic surgery clinics, 2020 - thoracic.theclinics.com
Lung cancer is the second most common cancer in men and women in the United States
and the leading cause of cancer death in both sexes. 1 Non–small cell histology represents …
and the leading cause of cancer death in both sexes. 1 Non–small cell histology represents …